Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Docusign, Inc. (NASDAQ: DOCU), a software company focused on digital agreements, eSignature, and Intelligent Agreement Management (IAM). Through these filings, investors can review the company’s official disclosures on financial performance, risk factors, governance, and key business developments.
Annual reports on Form 10-K typically include detailed discussions of DocuSign’s business, including its IAM platform, eSignature and contract lifecycle management offerings, customer base, and the risks and opportunities associated with its operations. Quarterly reports on Form 10-Q provide interim financial statements, management’s discussion and analysis, and updates on metrics such as revenue, subscription trends, billings, and cash flows.
Current reports on Form 8-K disclose material events, such as quarterly financial results and certain corporate governance changes. For example, DocuSign has used Form 8-K to report financial results for specific quarters and to announce board appointments and leadership roles. These filings help investors track significant developments between regular reporting periods.
Other filings, such as proxy statements and any Form 4 insider transaction reports, can offer additional insight into executive and director compensation, equity awards, and share ownership, as well as governance practices. Together, these documents form the regulatory record of DOCU as a Nasdaq-listed issuer.
On Stock Titan, SEC filings for DOCU are updated from the EDGAR system, and AI-powered summaries can assist readers by highlighting key points from lengthy documents like 10-Ks and 10-Qs. This can help users quickly understand DocuSign’s reported results, non-GAAP metrics, and material events without reading every page of each filing.
DOCUSIGN, INC. director Michael George Rosenbaum reported the exercise or conversion of restricted stock units into common stock. On March 3, 2026, he exercised 522 restricted stock units at a price of
DOCUSIGN, INC. director Anna Marrs reported mixed share activity. On March 3, 2026, she executed an open-market sale of 365 shares of common stock at $45.02 per share under a pre-arranged Rule 10b5-1 plan, leaving 11,889 shares of common stock directly owned.
On February 28, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 shares of common stock. Each RSU represents one share, with RSUs scheduled to vest quarterly starting May 29, 2025 over one year, subject to continued service, and they either vest or are canceled rather than expiring.
Anna Marrs reported an intended sale of
DocuSign, Inc. director Teresa Briggs reported an open-market sale of common stock. On February 27, 2026, she sold 364 shares at an average price of
Teresa Briggs reported proposed sales of Common stock via a Form 144 filing. The filing lists restricted stock entries dated
JPMorgan Chase & Co. filed a Schedule 13G reporting beneficial ownership of 13,712,039 shares of DocuSign, Inc. common stock, representing 6.4% of the outstanding class as of 12/31/2025. JPMorgan has sole power to vote and dispose of all these shares and no shared voting or dispositive power. The filing classifies JPMorgan as a parent holding company and lists several subsidiaries involved in holding the securities. JPMorgan certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of DocuSign.
DocuSign, Inc. Chief Financial Officer Blake Jeffrey Grayson reported selling 6,500 shares of the company’s common stock on January 9, 2026 at a price of $70 per share. The filing states that the transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, indicating it was pre-arranged rather than a discretionary trade. After this sale, Grayson directly held 111,713 shares of DocuSign common stock.
DocuSign, Inc. President and CEO Allan C. Thygesen reported planned sales of company common stock. On January 9, 2026, he completed three open-market sales under a Rule 10b5-1 trading plan. The reported transactions were sales of 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes note that the shares in each trade were sold within stated price ranges and that full price breakdowns are available on request. Following these sales, Thygesen directly beneficially owned 142,261 shares of DocuSign common stock.
A shareholder of DocuSign has filed a notice of proposed sale under Rule 144 to sell 26,250 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of
The shares to be sold were acquired as restricted stock units from the issuer on